BUSINESS
Rising US sales are boosting profit margins of large pharma companies
Profit margins of Sun Pharma, Dr Reddy’s Laboratories, Cipla and Zydus Lifesciences rose significantly from FY20 levels
BUSINESS
Moneycontrol Pro Panorama | Orders pile up for HAL, but execution risks remain
Moneycontrol's Pro Panorama September 3 edition: India sees biggest rise in coal demand, private lenders are winning the margin game, Pro Economic Tracker points to a slip in consumer sentiment, private consumption numbers not in line with granular data, and more
BUSINESS
Chart of the Day: India to see biggest rise in coal demand among major countries in 2024
Usage of thermal coal for power generation is estimated to have risen by 10 percent amid high electricity demand
BUSINESS
How power sector revival altered plans of CESC, Adani Power
CESC is scaling up green energy capacities. Adani Power, which once contemplated delisting, is aiming to double its electricity generation capacity base
BUSINESS
Deteriorating farm incomes in US can pose fresh challenges to agriculture inputs exporters
Falling crop prices and low income are feared to weigh on farm investments in the US
BUSINESS
Moneycontrol Pro Panorama | Investors eyeing quick bucks in IPOs should not throw caution to the winds
In Moneycontrol Pro Panorama August 27 edition: Indian pharma sector gets stronger, Generative AI and its purpose explained, rules essential for personal data law to work, cement makers unfazed by price slump, and more
BUSINESS
Chart of the Day: Large companies are getting stronger in Indian pharma market
Six of the top 10 companies by sales gained market share in the India pharma market in July 2024 on a moving annual turnover basis
BUSINESS
Large hospital chains withstand seasonal slowdown better in June 2024 quarter
Apollo Hospitals, Fortis Healthcare and Max Healthcare clocked decent growth in revenues despite a disruption to international patient flows
BUSINESS
Indian pharma market sees signs of recovery in July
Traction in acute therapy drugs can help India pharma market to improve growth rate in FY25
BUSINESS
Chart of the Day: India Inc is using its capital more efficiently than ever
The number of companies generating more than 15 percent return on equity has increased significantly from FY16-20
BUSINESS
Fortis Healthcare’s diagnostic unit is a grown-up child who never leaves home
The diagnostics unit is facing growth headwinds amid change in brand name
BUSINESS
With Renom, Suzlon takes pole position in wind energy services market
The company aims to gain leadership position in non-Suzlon wind energy OMS business
BUSINESS
Moneycontrol Pro Panorama | As markets rebound, is it business as usual?
In this edition of Moneycontrol Pro Panorama: Japan triggers a market tsunami but can it continue, explaining the slow bank credit growth, Bangladesh needs an out from this binary party trap, reforms in the Waqf — calls for accountability, and more
BUSINESS
Chart of the Day | India’s Buffett indicator has been flashing warning signals
India’s market capitalisation grew by fastest pace among major countries across the world in the last one year
BUSINESS
Sun Pharma: India remains bright spot amid uncertainty over hair loss drug
The company’s India business grew by more than 10 percent for four consecutive quarters outperforming the India pharma market
BUSINESS
Torrent Power is seeing merchant electricity demand at an opportune time
The power generation earnings are rising amid heightened capex and scale-up of renewable energy capacities
BUSINESS
Moneycontrol Pro Panorama | Power Grid and NTPC rev up capex in power sector
In today's edition of Moneycontrol Pro Panorama: Smaller banks likely to have a good Q1FY25, changing landscape in cement industry, diamond industry losing its shine, UP byelections a litmus test for Yogi, and more
BUSINESS
Chart of the Day: Why Suzlon's orders look more resilient this time
The company’s order book increased to the highest levels in its history in the June 2024 quarter
BUSINESS
In its biggest acquisition, Mankind Pharma tries to replicate its past success in M&A
Mankind Pharma is acquiring BSV at an enterprise value of Rs 13,630 crore. The last major acquisition it did was for Rs 1,872 crore.
TRENDS
How large IT companies stack up on growth rates after June quarter
TCS and LTIMindtree are projected to lead FY25 revenue growth rates. But Infosys is fast gaining momentum
BUSINESS
Renewed focus on agriculture sector in the Budget to support rural economy
The Union Budget 2024-25 has stepped up allocations for agriculture and rural development but could have done more in certain areas
BUSINESS
Economic Survey 2023-24 has the right prescription for coal power plants
The focus should be on adoption of cleaner coal and ultra super-critical technologies to reduce emissions, suggests the Economic Survey
BUSINESS
In Budget 2024, government should help accelerate capacity additions in power sector
The pace of capacity addition needs to be ramped up to meet the rising electricity needs of the country
BUSINESS
How Tata Power’s improved balance sheet is fuelling its capex
The net debt to equity ratio declined from 3 times in FY17 to less than one in FY24
